Annual Meeting Program - Society of Toxicology
Annual Meeting Program - Society of Toxicology
Annual Meeting Program - Society of Toxicology
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
<strong>Society</strong> <strong>of</strong> <strong>Toxicology</strong> 2008<br />
<strong>Program</strong> Description (Continued)<br />
Abstract #<br />
Monday Afternoon, March 17<br />
1:30 PM to 4:15 PM<br />
Room 6B<br />
SYMPOSIUM SESSION: DRUG-INDUCED MITOCHONDRIAL<br />
TOXICITY: NOVEL INSIGHTS–NOVEL TOOLS<br />
Chairperson(s): Yvonne Will, Pfizer, Inc., San Diego, CA and Urs<br />
Boelsterli, University <strong>of</strong> Connecticut School <strong>of</strong> Pharmacy, Storrs, CT.<br />
Endorsed by:<br />
Drug Discovery <strong>Toxicology</strong> Specialty Section<br />
Mechanisms Specialty Section*<br />
Mitochondria have been increasingly recognized as a target <strong>of</strong> drug toxicity<br />
resulting in disruption <strong>of</strong> bioenergetics and causing oxidant stress in sensitive<br />
organs including CNS, heart, and skeletal muscle. In addition, there is<br />
increasing awareness that mitochondria are key mediators <strong>of</strong> drug toxicity<br />
in a number <strong>of</strong> other organs including liver and kidney, <strong>of</strong>ten causing<br />
mitochondrial outer membrane permeabilization and release <strong>of</strong> cell death<br />
proteins. Furthermore, certain underlying disease states like diabetes, infections,<br />
or neurodegenerative diseases can greatly alter mitochondrial function<br />
and make the mitochondria more vulnerable to drug toxicity. Conventional<br />
in vitro approaches in drug discovery and development have <strong>of</strong>ten failed to<br />
detect mitochondrial dysfunction, and there are few animal models which<br />
would readily reveal mitochondrial liability. This symposium will focus on<br />
new approaches to detect, understand, and predict mitochondrial toxicity.<br />
These novel approaches include transcriptional fingerprinting <strong>of</strong> mitochondrial<br />
changes, transgenic mouse models, and novel in vitro tools.<br />
#556 1:30 DRUG-INDUCED MITOCHONDRIAL<br />
TOXICITY: NOVEL INSIGHTS–NOVEL<br />
TOOLS. Y. Will 1 and U. A. Boelsterli 2 . 1 Drug Safety<br />
Research and Development, Pfizer, San Diego,<br />
CA and 2 Department <strong>of</strong> Pharmaceutical Science,<br />
University <strong>of</strong> Connecticut, Storrs, CT.<br />
#557 1:45 TRANSCRIPTIONAL SIGNATURE OF<br />
MITOCHONDRIAL TOXICITIES. K. B.<br />
Wallace. Biochemistry & Molecular Biology,<br />
University <strong>of</strong> Minnesota Medical School, Duluth,<br />
MN.<br />
#558 2:15 MITOCHONDRIA IN DRUG-INDUCED<br />
LIVER INJURY (DILI). U. A. Boelsterli.<br />
Pharmaceutical Sciences, University <strong>of</strong> Connecticut,<br />
Storrs, CT.<br />
#559 2:45 INHIBITION OF ETHANOL EFFECTS BY<br />
MITOCHONDRIAL THIOREDOXIN-2. J.<br />
Hansen. School <strong>of</strong> Medicine, Emory University,<br />
Atlanta, GA. Sponsor: Y. Will.<br />
#560 3:15 LINKING MITOCHONDRIAL<br />
DYSFUNCTION TO HYPERGLYCEMIA:<br />
IMPACT OF MITOCHONDRIAL FIDELITY<br />
AND OXIDATIVE STRESS ON DIABETES<br />
AND ITS COMPLICATIONS. C. M. Palmeira.<br />
IMAR, Mitochondrial Research Group, Department<br />
<strong>of</strong> Zoology, University <strong>of</strong> Coimbra, Coimbra,<br />
Portugal.<br />
#561 3:45 STRATEGIES TO REDUCE NCE ATTRITION<br />
DUE TO MITOCHONDRIAL TOXICITY-<br />
DESIGNING NOVEL SCREENING<br />
METHODS. Y. Will. Drug Safety Research and<br />
Development, Pfizer, San Diego, CA.<br />
Abstract #<br />
Monday Afternoon, March 17<br />
1:30 PM to 4:15 PM<br />
Room 6E<br />
Developmental Basis <strong>of</strong> Disease<br />
SYMPOSIUM SESSION: ENVIRONMENTAL INFLUENCE ON<br />
FEMALE PUBERTY AND BREAST TUMORIGENESIS<br />
Chairperson(s): Elizabeth Maull, NIEHS, Research Triangle Park,<br />
NC and Coral Lamartiniere, University <strong>of</strong> Alabama at Birmingham,<br />
Birmingham, AL.<br />
Endorsed by:<br />
Carcinogenesis Specialty Section<br />
Mechanisms Specialty Section<br />
Molecular Biology Specialty Section*<br />
Reproductive and Developmental <strong>Toxicology</strong> Specialty Section<br />
Breast cancer is a complex disease, resulting from both genetic and environmental<br />
influences. Environmental exposures during critical windows<br />
<strong>of</strong> mammary gland development may be responsible for altering tissue<br />
susceptibility resulting in increased risk <strong>of</strong> future breast cancer. The pubertal<br />
hypothesis suggests that exogenous agents such as endocrine disrupting<br />
chemicals or other dietary factors, may mimic estrogen or influence their<br />
levels, such that the period <strong>of</strong> rapid development <strong>of</strong> the mammary gland is<br />
extended, putting the gland at higher risk for a transition to carcinogenesis.<br />
The NIEHS and NCI established the Breast Cancer and the Environment<br />
Research Centers (BCERC) Network, a unique multidisciplinary, translational<br />
grant program that includes basic biology, epidemiology, and<br />
community outreach and translation components to address the pubertal<br />
hypothesis. A primary objective <strong>of</strong> the BCERC Network is to explore the<br />
influence <strong>of</strong> a select set <strong>of</strong> exposures and activities on the onset <strong>of</strong> breast<br />
development and progression through puberty, early onset <strong>of</strong> puberty being<br />
among the most reliable risk factors for future beast cancer. Research within<br />
the Network spans a spectrum <strong>of</strong> biological organization: molecular mechanisms<br />
controlling regulation <strong>of</strong> differentiation <strong>of</strong> gland stem cells; insights<br />
into genomic and proteomic pre-disposition for disease; the impact <strong>of</strong> environmental<br />
exposures (including diet and obesity) at sensitive windows <strong>of</strong><br />
development on gland development and the future risk <strong>of</strong> developing breast<br />
cancer as well as a cohort study <strong>of</strong> puberty designed to look at both environmental<br />
and genetic factors, and when possible their interactions, evaluating<br />
the impact <strong>of</strong> environmental exposures (broadly defined to include dietary,<br />
endocrine disruptors, consumer product use and socioeconomic factors) on<br />
progression to and through puberty in young girls. The aim <strong>of</strong> this symposium<br />
is to present the latest findings relating early environmental exposures<br />
with alterations in pubertal milestones that predispose towards breast cancer.<br />
#562 1:30 ENVIRONMENTAL INFLUENCE ON<br />
FEMALE PUBERTY AND BREAST<br />
TUMORIGENESIS. E. A. Maull 1 , S. Lynch 2 ,<br />
D. Winn 2 , G. Collman 1 and L. Reinlib 1 . 1 National<br />
Institute <strong>of</strong> Environmental Health Sciences, RTP, NC<br />
and 2 National Cancer Institute, Rockville, MD.<br />
#563 1:45 THE EFFECT OF ENVIRONMENTAL<br />
EXPOSURES ON MAMMARY STEM CELLS<br />
DURING PUBERTY. M. Barcellos-H<strong>of</strong>f 1 , I.<br />
Illa-Bochaca 1 , C. Lamartiniere 2 and Z. Werb 3 .<br />
1<br />
Lawrence Berkeley National Laboratory, Berkeley,<br />
CA, 2 University <strong>of</strong> Alabama, Birmingham, AL<br />
and 3 University <strong>of</strong> California, San Francisco, San<br />
Francisco, CA.<br />
#564 2:15 PRENATAL EXPOSURE TO BISPHENOL A<br />
(BPA) INDUCES GENOMIC ALTERATIONS<br />
IN THE RAT MAMMARY GLAND. J. Russo 1 ,<br />
J. Pereira 1 , R. Moral 1 , C. Lamartiniere 2 and I. H.<br />
Russo 1 . 1 Fox Chase Cancer Center, Philadelphia,<br />
PA and 2 University <strong>of</strong> Alabama at Birmingham,<br />
Birmingham, AL.<br />
Monday<br />
up-to-date information at www.toxicology.org 133